Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,108.09 +44.05 (+4.14%)
Official Closing Price Updated: 7:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,652,838
Open 1,077.00
Bid (Size) 1,107.00 (40)
Ask (Size) 1,108.40 (440)
Prev. Close 1,064.04
Today's Range 1,075.96 - 1,117.66
52wk Range 623.78 - 1,117.66
Shares Outstanding 956,580,893
Dividend Yield 0.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗
Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth. 
Via Stocktwits
Topics Initial Public Offering
News headline image
Eli Lilly Confirms Plan To Buy Ventyx Biosciences In $1.2 Billion Deal ↗
Eli Lilly confirmed its $1.2 billion plan late Wednesday to acquire Ventyx Biosciences. Ventyx stock ran up nearly 40%. 
Via Investor's Business Daily

Performance

YTD
+2.6%
+2.6%
1 Month
+11.1%
+11.1%
3 Month
+31.0%
+31.0%
6 Month
+40.8%
+40.8%
1 Year
+43.3%
+43.3%

More News

Read More
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Trillion-Dollar Treatment: Eli Lilly Solidifies Dominance as Obesity Drug Boom Enters New Era
Via MarketMinute
Topics Economy
Eli Lilly Stock Rises After Hours On UBS ‘Buy’ Call Ahead Of Oral Obesity Pill Launch — GLP-1 Battle With Novo Heats Up ↗
Via Stocktwits
News headline image
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗
Via Stocktwits
News headline image
3 Drug Stocks to Buy at a Discount ↗
Via The Motley Fool
News headline image
The Valuation Wall: Nasdaq Momentum Stalls as the 'Great Rotation' of 2026 Takes Hold
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Great Rotation: How the 2026 Market Rally Outgrew the 'Magnificent Seven'
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
This Could Be Key to Pfizer's Turnaround in 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Shares Surge On Report Of Potential Ventyx Acquisition ↗
Via Benzinga
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
The Alpha Renaissance: Goldman Sachs Reports Record Hedge Fund Gains in 2025
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Why Did Eli Lilly Shares Surge Today? Key Factors ↗
Via Talk Markets
News headline image
Eli Lilly (LLY) Stock Is Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence
News headline image
My Top 5 Stocks to Buy in Early 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock ↗
Via Benzinga
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Via The Motley Fool
News headline image
Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Ventyx Biosciences Launches On Rumored $1 Billion Eli Lilly Takeover ↗
Via Investor's Business Daily
News headline image
The Trillion-Dollar Pivot: Eli Lilly Unleashes Volume-Led Strategy to Cement Obesity Market Dominance in 2026
Via MarketMinute
Topics Economy
News headline image
S&P 500 Shatters Records: Index Crosses 6,944 as Tech Giants and Healthcare Titans Lead the Charge
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗
Via Stocktwits
News headline image
Eli Lilly Inks Deal With Nimbus Therapeutics To Find New Obesity Drug With AI ↗
Via Stocktwits
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
Via MarketMinute
Topics Artificial Intelligence Economy Government

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,108.09
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 01/07/26 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,059.98B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,060B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.